国际中医中药杂志
國際中醫中藥雜誌
국제중의중약잡지
INTERNATIONAL JOURNAL OF TRIDITIONAL CHINESE MEDICINE
2012年
8期
689-691
,共3页
2型糖尿病%焦虑%糖化血红蛋白%主观幸福感
2型糖尿病%焦慮%糖化血紅蛋白%主觀倖福感
2형당뇨병%초필%당화혈홍단백%주관행복감
Type 2 diabetes%Anxiety%Glycated hemoglobin%Subjective well-being
目的 探讨加味逍遥丸联合帕罗西汀对2型糖尿病伴发焦虑患者在焦虑、糖代谢及主观幸福感方面的影响.方法 选择2008年1月至2010年12月在首都师范大学社区卫生服务中心、北京宣武医院等多家医疗机构就诊的60例2型糖尿病伴发焦虑患者,按登记顺序随机分为两组各30例.治疗组予加味逍遥丸合帕罗西汀口服,对照组口服单纯帕罗西汀.观察治疗前后糖化血红蛋白(HbAlc)水平、特质焦虑量表(TAI)评分、纽芬兰纪念大学主观幸福感量表(MUNSH)评分的变化,观察时间为6周.结果 治疗组与对照组患者治疗后TAI评分[分别为(38.89±6.70)分、(45.29±6.55)分]均较同组治疗前[分别为(54.07±6.41)分、(56.33±6.01)分]明显下降(P＜0.05),且治疗组治疗后评分优于对照组(P＜0.05):HbAlc水平组内及组间比较[治疗后分别为(8.21±2.07)％、(7.92±1.90)％；治疗前分别为(8.14±2.69)％、(8.07±2.11)％]均无明显变化(P＞0.05)；治疗组治疗后MUNSH评分[(44.53±6.28)分]较同组治疗前[(40.49±5.22)分]明显提高(P＜0.05),且与对照组治疗后(57.56±6.39)分,比较,差异有统计学意义(P＜0.05).结论 加味逍遥丸联合帕罗西汀可明显降低患者的焦虑程度,提高主观幸福感.
目的 探討加味逍遙汍聯閤帕囉西汀對2型糖尿病伴髮焦慮患者在焦慮、糖代謝及主觀倖福感方麵的影響.方法 選擇2008年1月至2010年12月在首都師範大學社區衛生服務中心、北京宣武醫院等多傢醫療機構就診的60例2型糖尿病伴髮焦慮患者,按登記順序隨機分為兩組各30例.治療組予加味逍遙汍閤帕囉西汀口服,對照組口服單純帕囉西汀.觀察治療前後糖化血紅蛋白(HbAlc)水平、特質焦慮量錶(TAI)評分、紐芬蘭紀唸大學主觀倖福感量錶(MUNSH)評分的變化,觀察時間為6週.結果 治療組與對照組患者治療後TAI評分[分彆為(38.89±6.70)分、(45.29±6.55)分]均較同組治療前[分彆為(54.07±6.41)分、(56.33±6.01)分]明顯下降(P＜0.05),且治療組治療後評分優于對照組(P＜0.05):HbAlc水平組內及組間比較[治療後分彆為(8.21±2.07)％、(7.92±1.90)％；治療前分彆為(8.14±2.69)％、(8.07±2.11)％]均無明顯變化(P＞0.05)；治療組治療後MUNSH評分[(44.53±6.28)分]較同組治療前[(40.49±5.22)分]明顯提高(P＜0.05),且與對照組治療後(57.56±6.39)分,比較,差異有統計學意義(P＜0.05).結論 加味逍遙汍聯閤帕囉西汀可明顯降低患者的焦慮程度,提高主觀倖福感.
목적 탐토가미소요환연합파라서정대2형당뇨병반발초필환자재초필、당대사급주관행복감방면적영향.방법 선택2008년1월지2010년12월재수도사범대학사구위생복무중심、북경선무의원등다가의료궤구취진적60례2형당뇨병반발초필환자,안등기순서수궤분위량조각30례.치료조여가미소요환합파라서정구복,대조조구복단순파라서정.관찰치료전후당화혈홍단백(HbAlc)수평、특질초필량표(TAI)평분、뉴분란기념대학주관행복감량표(MUNSH)평분적변화,관찰시간위6주.결과 치료조여대조조환자치료후TAI평분[분별위(38.89±6.70)분、(45.29±6.55)분]균교동조치료전[분별위(54.07±6.41)분、(56.33±6.01)분]명현하강(P＜0.05),차치료조치료후평분우우대조조(P＜0.05):HbAlc수평조내급조간비교[치료후분별위(8.21±2.07)％、(7.92±1.90)％；치료전분별위(8.14±2.69)％、(8.07±2.11)％]균무명현변화(P＞0.05)；치료조치료후MUNSH평분[(44.53±6.28)분]교동조치료전[(40.49±5.22)분]명현제고(P＜0.05),차여대조조치료후(57.56±6.39)분,비교,차이유통계학의의(P＜0.05).결론 가미소요환연합파라서정가명현강저환자적초필정도,제고주관행복감.
Objective To explore the influence of integrated Chinese and western medicine therapy on anxiety,sugar metabolism and subjective well-being for type 2 diabetes Patients associated with anxiety.Methods Use glycated hemoglobin (HbAlc),trait anxiety inventory(TAI),and Memorial University of Newfoundland Scale of Happiness (MUNSH) to evaluate the condition of 60 patients with type 2 diabetes associated with anxiety.The patients participated in the study were randomly divided into Western medicine therapy group(control group)and integrated traditional Chinese and Western medicine therapy group (experimental group),with 30 cases in each group.The control group was treated with paroxetine while the experimental group was treated with paroxetine plus Jiawei-Xiaoyaowan.6 weeks after treatment,we tested the HbAlc level.TAI score and MUNSH score of those patients.Results After 6 weeks,the TAI score of patients in both experimental group and control group have obviously decreased (before treatment:54.07±6.41 and 56.33 ±6.01,respectively; after treatment:38.89±6.70 and 45.29±6.55,respectively) and the difference was statistically significant (P＜0.05).And the TAI score of the two groups after treatment was significantly different (P＜0.05).For both experimental and control groups,the HbA1e level were not obviously changed before and after the study with P＞0.05 (before treatment:8.14±2.69 and 8.07±2.11,respectively; after treatment:8.21±2.07 and 7.92± 1.90,respectively).Comparison between groups also showed no significant difference.MUNSH score have obviously increased in experimental group (before treatment:40.49±5.22; after treatment:44.53 ± 6.28,P＜0.05).The result of comparison between the two groups after treatment shows that MUNSH score of patients in the experimental group were obviously improved compared with patients in the control group (57.56 ±6.39),and the difference was statistically significant (P＜0.05).Conclusion The integrated traditional Chinese and western medicine therapy can obviously release anxiety and enhance subjective well-being in patients with cerebral infarction associated with anxiety.
